Your Article Summary
New treatment options for fibromyalgia: critical appraisal of duloxetine
Neuropsychiatric Disease and Treatment, 05/13/08
Uceyler N et al. - So far two randomized, placebo-controlled trials have investigated the short-term safety and efficacy of duloxetine 60 mg/day and 120 mg/day in patients suffering from FMS over a period of 12 weeks. Both dosages were superior to placebo in pain relief, and improvement in quality of life and depressive symptoms. The analgesic effect was largely independent of the antidepressant action of duloxetine. The higher dose of 120 mg/day further reduced the tender point count and elevated the tender point pain thresholds. Only mild to moderate adverse effects were reported. Duloxetine 60 mg/day and 120 mg/day has proven to be beneficial in the treatment of FMS symptoms.
Related Articles
Changes in Hippocampal Metabolites After Effective Treatment for Fibromyalgia: A Case Study
The Clinical Journal of Pain, 10/20/09
Relevance Score: 94%
Womens narratives on experiences of work ability and functioning in fibromyalgia
Musculoskeletal Care, 10/23/09
Relevance Score: 93%
General symptom reporting in female fibromyalgia patients and referents: a population-based case-referent study
BMC Public Health, 11/04/09
Relevance Score: 90%
Fibromyalgia: From treatment to rehabilitation
European Journal of Pain, 11/17/09
Relevance Score: 89%
Are chronic fatigue syndrome and fibromyalgia the same? Implications for the provision of appropriate mental health intervention
Journal of Psychiatric and Mental Health Nursing, 11/16/09
Relevance Score: 89%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Changes in the Vaginal Microenvironment with Metronidazole Treatment for Bacterial Vaginosis in Early Pregnancy
Journal of Women's Health, 12/10/09
Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial
The Lancet - Early Online Publication, 12/10/09
Cause for controversy? Infliximab in the treatment of ulcerative colitis: an update
Clinical and Experimental Gastroenterology, 12/10/09
Today in Mental Health...keeping you current
Receive free subspecialty "5-minute updates" via email
Psychometric Properties of the Patient Health Questionnaire–15 (PHQ-15) for Measuring the Somatic Symptoms of Psychiatric Outpatients
Psychosomatics, 12/10/09
Depression and Diabetes: Factors Associated With Major Depression at Five-Year Follow-Up
Psychosomatics, 12/10/09
Lack of association of three GRIN2B polymorphisms with bipolar disorder
World Journal of Biological Psychiatry, 12/10/09
Today in Ortho/Rheum...keeping you current
Receive free subspecialty "5-minute updates" via email
Planning, Leisure-Time Physical Activity, and Coping Self-Efficacy in Persons With Spinal Cord Injury: A Randomized Controlled Trial
Archives of Physical Medicine and Rehabilitation, 12/10/09
Randomized Controlled Trial for Efficacy of Intra-Articular Injection for Adhesive Capsulitis: Ultrasonography-Guided Versus Blind Technique
Archives of Physical Medicine and Rehabilitation, 12/10/09
Prognostic factors for long-term sickness absence among employees with neck-shoulder and low-back pain
Scandinavian Journal of Work, Environment & Health, 12/10/09

See Latest Articles